Breast Cancer: Advances in Molecular Imaging, An Issue of PET Clinics
- 1st Edition, Volume 18-4 - September 4, 2023
- Imprint: Elsevier
- Editors: Gary A. Ulaner, Amy M. Fowler
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 1 8 2 0 3 - 7
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 8 2 0 4 - 4
In this issue, guest editors bring their considerable expertise to this important… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteIn this issue, guest editors bring their considerable expertise to this important topic.
-
Contains 10 relevant, practice-oriented topics including current dedicated breast imaging: recent advances and current limitations; breast cancer systemic staging (comparison of CT, bone scan, FDG PET); breast cancer treatment response (comparison of CT, bone scan, FDG PET); artificial intelligence and machine learning in breast cancer imaging; molecular classification of breast cancer; and more.
-
Provides in-depth clinical reviews on breast cancer: advances in molecular imaging, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Nuclear radiologists
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- CME Accreditation Page
- Preface
- Molecular Classification of Breast Cancer
- Key points
- Introduction
- Summary
- Clinics care points
- Disclosure
- Breast Cancer Screening and Diagnosis: Recent Advances in Imaging and Current Limitations
- Key points
- Introduction
- Mammography
- Supplemental screening
- Breast MR imaging
- Dedicated breast radionuclide imaging systems
- Future directions
- Clinics care points
- Disclosure
- Metabolic Positron Emission Tomography in Breast Cancer
- Key points
- Introduction
- Principles and technique of 18F-FDG PET/CT in breast cancer
- Tumor histology, receptor status, and visualization on PET/CT
- 18F-Fluorodeoxyglucose PET primary breast cancer detection
- Initial staging
- Treatment response
- Suspected recurrence outside the breast
- 18F-Fluciclovine
- Summary
- Disclosure
- Molecular Breast Imaging and Positron Emission Mammography
- Key points
- Introduction
- Molecular breast imaging
- Positron emission mammography
- Summary
- Clinics care points
- Disclosure
- Breast Cancer Systemic Staging (Comparison of Computed Tomography, Bone Scan, and 18F-Fluorodeoxyglucose PET/Computed Tomography)
- Key points
- Introduction
- Technical aspects and specificities of breast cancer imaging
- Baseline staging of breast cancer
- Summary
- Clinics care points
- Disclosure
- Evaluation of Treatment Response in Patients with Breast Cancer
- Key points
- Introduction
- Neoadjuvant therapy response assessment
- Anatomic imaging techniques
- Metastatic breast cancer therapy response assessment
- Other FDA-approved radionuclides
- Summary
- Clinics care points
- Disclosure
- Estrogen Receptor-Targeted and Progesterone Receptor-Targeted PET for Patients with Breast Cancer
- Key points
- Introduction
- Estrogen receptor-targeted imaging
- Progesterone receptor-targeted imaging
- Summary
- Clinics care points
- Disclosure
- Human Epidermal Growth Factor Receptor 2/Human Epidermal Growth Factor Receptor 3 PET Imaging: Challenges and Opportunities
- Key points
- Human epidermal growth factor receptor 2/human epidermal growth factor receptor 3-positive breast cancer introduction
- Clinical trials: PET imaging of human epidermal growth factor receptor 2/human epidermal growth factor receptor 3
- Preclinical molecular imaging of human epidermal growth factor receptor 2/human epidermal growth factor receptor 3 on the horizon
- Future directions
- Summary
- Clinics care points
- Disclosure
- Funding
- Other Novel PET Radiotracers for Breast Cancer
- Key points
- Introduction
- 18F-fluciclovine PET imaging
- PET imaging with Poly (ADP-ribose) polymerase radiotracers
- Fibroblast activation protein inhibitor PET imaging
- [18F]Fluoro-3′-deoxy-3′-L-fluorothymidine PET imaging
- [18F]Fluoromisonidazole PET imaging
- ImmunoPET imaging
- Summary
- Clinics care points
- Disclosure
- AI-Enhanced PET and MR Imaging for Patients with Breast Cancer
- Key points
- Introduction
- Summary
- Clinics care points
- Disclosure
- Edition: 1
- Volume: 18-4
- Published: September 4, 2023
- Imprint: Elsevier
- Language: English
- Hardback ISBN: 9780443182037
- eBook ISBN: 9780443182044
GU
Gary A. Ulaner
Affiliations and expertise
Associate Attending Radiologist, Memorial Sloan Kettering Cancer Center, New York, New YorkAF
Amy M. Fowler
Affiliations and expertise
Assistant Professor, Section of Breast Imaging and Intervention, Department of Radiology, University of Wisconsin – Madison